These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 19326058

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Plasma cell leukemia: Clinicopathologic, immunophenotypic and cytogenetic characteristics of 4 cases.
    Alghasham N, Alnounou R, Alzahrani H, Alsharif F.
    Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):71-7. PubMed ID: 25929729
    [Abstract] [Full Text] [Related]

  • 23. Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics.
    García-Sanz R, Orfão A, González M, Tabernero MD, Bladé J, Moro MJ, Fernández-Calvo J, Sanz MA, Pérez-Simón JA, Rasillo A, Miguel JF.
    Blood; 1999 Feb 01; 93(3):1032-7. PubMed ID: 9920853
    [Abstract] [Full Text] [Related]

  • 24. [Primary plasma cell leukemia. Report of five cases].
    Mendoza MG, Valladares X, Roa M, Reyes M, Osorio R, Undurraga MS, Legües ME, Cabrera ME, Peña C.
    Rev Med Chil; 2019 Feb 01; 147(1):18-23. PubMed ID: 30848760
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Genomics of Plasma Cell Leukemia.
    Rojas EA, Gutiérrez NC.
    Cancers (Basel); 2022 Mar 21; 14(6):. PubMed ID: 35326746
    [Abstract] [Full Text] [Related]

  • 27. Occurrence and type of chromosomal abnormalities in consecutive malignant monoclonal gammopathies: correlation with survival.
    Lisse IM, Drivsholm A, Christoffersen P.
    Cancer Genet Cytogenet; 1988 Oct 01; 35(1):27-36. PubMed ID: 3180005
    [Abstract] [Full Text] [Related]

  • 28. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
    Nishida K, Tamura A, Nakazawa N, Ueda Y, Abe T, Matsuda F, Kashima K, Taniwaki M.
    Blood; 1997 Jul 15; 90(2):526-34. PubMed ID: 9226151
    [Abstract] [Full Text] [Related]

  • 29. Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients.
    An G, Qin X, Acharya C, Xu Y, Deng S, Shi L, Zang M, Sui W, Yi S, Li Z, Hao M, Feng X, Jin F, Zou D, Qi J, Zhao Y, Tai YT, Wang J, Qiu L.
    Ann Hematol; 2015 Feb 15; 94(2):257-64. PubMed ID: 25231928
    [Abstract] [Full Text] [Related]

  • 30. [A primitive plasma cell leukemia with immunoglobulin (Ig) E].
    Rachidi M, Lazarian G, Letestu R, Lusina D, Desbene C, Vidal V, Eclache V, Baran-Marszak F, Cymbalista F, Fleury C.
    Ann Biol Clin (Paris); 2019 Oct 01; 77(5):557-561. PubMed ID: 31512579
    [Abstract] [Full Text] [Related]

  • 31. Significantly better prognosis for patients with primary plasma cell leukemia than for patients with secondary plasma cell leukemia.
    Cha CH, Park CJ, Huh JR, Chi HS, Suh CW, Kang YK.
    Acta Haematol; 2007 Oct 01; 118(3):178-82. PubMed ID: 17934254
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome.
    Todoerti K, Agnelli L, Fabris S, Lionetti M, Tuana G, Mosca L, Lombardi L, Grieco V, Bianchino G, D'Auria F, Statuto T, Mazzoccoli C, De Luca L, Petrucci MT, Morabito F, Offidani M, Di Raimondo F, Falcone A, Omede' P, Tassone P, Boccadoro M, Palumbo A, Neri A, Musto P.
    Clin Cancer Res; 2013 Jun 15; 19(12):3247-58. PubMed ID: 23599371
    [Abstract] [Full Text] [Related]

  • 35. A case of CD138-/CD19+/CD4+ IgD plasma cell leukemia.
    Sorigue M, Juncà J, Gassiot S, Millá F, Mate JL, Navarro JT.
    Cytometry B Clin Cytom; 2015 Jan 15; 88(1):69-73. PubMed ID: 24715427
    [Abstract] [Full Text] [Related]

  • 36. Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective Cohort Study.
    Wang H, Zhou H, Zhang Z, Geng C, Chen W.
    Turk J Haematol; 2020 May 06; 37(2):91-97. PubMed ID: 31769277
    [Abstract] [Full Text] [Related]

  • 37. Plasma Cell Leukaemia: A Rare Yet Aggressive Plasma Cell Dyscrasia With A Very Poor Response To Conventional Therapy.
    Khan N, Raza SS, Khan UI, Hafez I, Abdullah MA, Hassan M, Rukh Hijaz AS, Hussain AK, Nadeem MD.
    J Ayub Med Coll Abbottabad; 2019 May 06; 31(2):272-275. PubMed ID: 31094130
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Single-Center Experience of Patients with Plasma Cell Leukemia in the Era of New Therapeutics.
    Dampmann M, Flossdorf S, Keyl J, Reinhardt HC, Hanoun C.
    Acta Haematol; 2024 May 22; ():1-8. PubMed ID: 38763126
    [Abstract] [Full Text] [Related]

  • 40. Plasma cell leukemia mimicking acute myeloid leukemia.
    Moore EM, Roth CG.
    Blood; 2016 May 12; 127(19):2359. PubMed ID: 28092885
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.